cereblon modulator

This page covers all cereblon modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting cereblon.

Targets

cereblon

Phase 2 pipeline (1)

• CC-220 · Celgene · Immunology
  CC-220 is a small molecule that modulates the activity of cereblon, an E3 ubiquitin ligase, leading to the degradation of specific proteins involved in inflammation and immune responses.